PKCα–GSK3β–NF-κB signaling pathway and the possible involvement of TRIM21 in TRAIL-induced apoptosis
Authors:
- 1 June 2016
- journal article
- Published by Canadian Science Publishing in Biochemistry and Cell Biology
- Vol. 94 (3) , 256-264
Abstract
Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) is a highly promising therapeutic agent for cancer treatment, owing to its ability to selectively target tumor cells for cell death while having little effect on most normal cells. However, recent research has found that many cancers, including non-small cell lung cancer (NSCLC), display resistance to TRAIL. Therefore, it is important to elucidate the molecular mechanisms governing the resistance of tumor cells to TRAIL treatment. In this study, we show that GSK3β antagonized TRAIL-induced apoptosis in H1299 NSCLC cells, and determined that the PKCα isozyme is an upstream regulator of GSK3β that phosphorylates and inactivates GSK3β, thereby sensitizing cancer cells to TRAIL-induced apoptosis. Furthermore, we demonstrated that the anti-apoptotic effect of GSK3β is mediated by the NF-κB pathway, whereas the tripartite motif 21 (TRIM21) was able to inhibit the activation of NF-κB by GSK3β, and leads to the promotion of cell apoptosis. Taken together, our study further delineated the underpinning mechanism of resistance to TRAIL-induced apoptosis in H1299 cells, and provided new clues for sensitizing NSCLC cells to TRAIL therapy.Keywords
This publication has 55 references indexed in Scilit:
- Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivityNature Biotechnology, 2011
- Celecoxib Promotes c-FLIP Degradation through Akt-Independent Inhibition of GSK3Cancer Research, 2011
- NF-κB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAILBMC Cancer, 2010
- Downregulation of active IKKβ by Ro52-mediated autophagyMolecular Immunology, 2010
- Ro52-mediated Monoubiquitination of IKK Down-regulates NF- B SignallingThe Journal of Biochemistry, 2009
- Glycogen Synthase Kinase-3 Inhibition Induces Glioma Cell Death through c-MYC, Nuclear Factor-κB, and Glucose RegulationCancer Research, 2008
- Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4Cell Death & Differentiation, 2008
- Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor κB target genes and induction of apoptosis in chronic lymphocytic leukemia B cellsBlood, 2007
- The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathwaysProgress in Neurobiology, 2006
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995